Advertisement
UK markets close in 22 minutes
  • FTSE 100

    8,310.94
    +97.45 (+1.19%)
     
  • FTSE 250

    20,368.40
    +203.86 (+1.01%)
     
  • AIM

    775.86
    +4.33 (+0.56%)
     
  • GBP/EUR

    1.1639
    -0.0021 (-0.18%)
     
  • GBP/USD

    1.2552
    -0.0012 (-0.09%)
     
  • Bitcoin GBP

    51,078.77
    +843.93 (+1.68%)
     
  • CMC Crypto 200

    1,316.33
    -48.80 (-3.57%)
     
  • S&P 500

    5,195.50
    +14.76 (+0.28%)
     
  • DOW

    38,962.29
    +110.02 (+0.28%)
     
  • CRUDE OIL

    78.00
    -0.48 (-0.61%)
     
  • GOLD FUTURES

    2,321.70
    -9.50 (-0.41%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,409.68
    +234.47 (+1.29%)
     
  • CAC 40

    8,068.20
    +71.56 (+0.89%)
     

Ingevity (NGVT) Gains on Demand Strength and Growth Actions

Ingevity Corporation NGVT is poised to benefit from higher demand and prices in its industrial specialties and engineered polymers businesses and its actions to drive growth.

Shares of Ingevity, a Zacks Rank #2 (Buy) stock, are down 6.4% over the past year against the 16.6% decline of its industry.

 

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research



Ingevity is benefiting from a recovery in demand for its products from the pandemic-induced slowdown, which is leading to higher volumes and prices. The company’s Performance Chemicals segment is riding on solid demand as well as higher selling prices in engineered polymers and industrial specialties. The company is also benefiting from increased demand for process purification products in the Performance Materials unit. Strong demand is expected to continue to support its top line and margins moving ahead.

Ingevity is also taking a number of actions to drive long-term growth. It remains committed to invest organically. The company also remains focused on optimizing its operations and inventory to provide outstanding service to customers. It is also taking price hike actions to mitigate cost inflation. Ingevity is also committed to capturing the maximum value for its products.

The acquisition of Ozark Materials will also strengthen the company’s position in the paving construction industry and enable it to better serve its customers. Ozark Materials is a leading manufacturer of pavement marking materials, including thermoplastic pavement markings, waterborne traffic paints and preformed thermoplastics. Ingevity expects the entity to generate revenues of around $150 million and EBITDA margins of roughly 20% in calendar 2023.

The company’s $60 million investment to buy an equity stake in Nexeon Limited also establishes its presence in the electric vehicle (EV) market along with providing opportunities to expand its activated carbon business. The company’s investment includes a commitment to jointly develop technology for EVs using Ingevity’s activated carbon to improve the performance of lithium-ion batteries.

ADVERTISEMENT

 

Ingevity Corporation Price and Consensus

 

Ingevity Corporation Price and Consensus
Ingevity Corporation Price and Consensus

Ingevity Corporation price-consensus-chart | Ingevity Corporation Quote

 

Stocks to Consider

Other top-ranked stocks worth considering in the basic materials space include Albemarle Corporation ALB, Sociedad Quimica y Minera de Chile S.A. SQM and The Chemours Company CC.

Albemarle, currently sporting a Zacks Rank #1 (Strong Buy), has a projected earnings growth rate of 425.7% for the current year. The consensus estimate for ALB's current-year earnings has been revised 67.9% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.

Albemarle’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 24.2%, on average. ALB has gained around 27% in a year.

Sociedad has a projected earnings growth rate of 530.7% for the current year. The Zacks Consensus Estimate for SQM’s current-year earnings has been revised 18.8% upward in the past 60 days.

Sociedad’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, the average being 20.7%. SQM has rallied roughly 89% in a year. The company currently carries a Zacks Rank #2.

Chemours has a projected earnings growth rate of 40% for the current year. The Zacks Consensus Estimate for CC's current-year earnings has been revised 6.9% upward in the past 60 days.

Chemours’ earnings beat the Zacks Consensus Estimate in three of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 28.3%, on average. CC has gained around 11% in a year and presently carries a Zacks Rank #2.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Albemarle Corporation (ALB) : Free Stock Analysis Report
 
Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report
 
The Chemours Company (CC) : Free Stock Analysis Report
 
Ingevity Corporation (NGVT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research